Zelira Therapeutics's market cap is currently $2.57M. The company's EPS TTM is $-0.06794267999999999; its P/E ratio is ―; Zelira Therapeutics is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
